In my latest post on my blog ( bkoffman.blogspot.com ), I have an interview with Dr. Kipps from ASCO earlier this year that helps explain why ABT-199 could be such a potent (and dangerous) weapon in fighting CLL and why the development of therapies directed against ROR1 are so exciting.
I love how Dr. Kipps uses analogies to explain and make accessible complex concepts. His general discussion on the nature of cancer is very thoughtful.
I comment on where I see the need for more research and my excitement and my worries.
Admin: Link edited (The HU site needs a space before any characters following the link)